⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTR News
Nektar Therapeutics
NKTR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
NKTR
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit
prnewswire.com
NKTR
NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
NKTR
Pomerantz LLP Announces Commencement of Class Action Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
ROSEN, A LEADING LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
accessnewswire.com
NKTR
Pomerantz LLP Announces Commencement of Class Action Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
NKTR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
globenewswire.com
NKTR
NKTR DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
globenewswire.com
NKTR
Pomerantz LLP Announces Class Action Litigation Filing Against Nektar Therapeutics, Inc. – NKTR
accessnewswire.com
NKTR
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
globenewswire.com
NKTR